Literature DB >> 27093797

[Ligands of RAGE-Proteins: Role in Intercellular Communication and Pathogenesis of Inflammation].

Yu A Uspenskaya, Yu K Komleva, E A Pozhilenkova, V V Salmin, O L Lopatina, A A Fursov, P V Lavrentiev, O A Belova, A B Salmina.   

Abstract

The review contains data on the diversity of endogenous ligands of RAGE receptors (receptor for advanced glycation end products) that play an important role in the signal transduction in (patho) physiological conditions. RAGE takes part in various physiological processes like cell growth and survival, apoptosis and regeneration. They serve as regulators of inflammatory reactions due to their ability to induce secretion of cytokines and chemokines. In addition, they facilitate elimination of apoptotic cells and mediate innate immune response. We discuss mechanisms of soluble RAGE production as well as the role of membrane and soluble forms of the receptor in cell signaling. Several endogenous ligands of RA GE are well-known: advanced glycation end products (AGE), amyloid-beta (Aβ), nuclear high mobility group box 1 proteins (HMGB1), and calcium-binding proteins S100A4, S100A8/A9, S100A12 u S100B. The review is focused on the mechanisms of the ligands production, their secretion from the cells of various origin, interaction with RAGE, and associated intracellular signal transduction pathways. Special attention is paid to the role of RAGE in pathogenesis of inflammation, particularly, in brain injury and neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 27093797     DOI: 10.15690/vramn566

Source DB:  PubMed          Journal:  Vestn Ross Akad Med Nauk        ISSN: 0869-6047


  2 in total

1.  RAGE deficiency attenuates the protective effect of Lidocaine against sepsis-induced acute lung injury.

Authors:  Zhuo Zhang; Jie Zhou; Changli Liao; Xiaobing Li; Minghua Liu; Daqiang Song; Xian Jiang
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

Review 2.  Role of the S100 protein family in rheumatoid arthritis.

Authors:  Yuan-Yuan Wu; Xiao-Feng Li; Sha Wu; Xue-Ni Niu; Su-Qin Yin; Cheng Huang; Jun Li
Journal:  Arthritis Res Ther       Date:  2022-01-31       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.